Why the study?
PCOS is associated with increased cardiovascular risk and potential subclinical ventricular dysfunction, but the utility of novel echocardiographic markers like IVA for early detection needed assessment.
Do patients with polycystic ovary syndrome exhibit subclinical ventricular dysfunction detectable by isovolumic acceleration and myocardial performance index compared to matched controls?
Do patients with polycystic ovary syndrome exhibit subclinical ventricular dysfunction detectable by isovolumic acceleration and myocardial performance index compared to matched controls?
This cross-sectional study aimed to evaluate subclinical ventricular dysfunction in PCOS using novel echocardiographic markers like isovolumic acceleration, though the reported results are truncated.
IVA may flag subclinical dysfunction in PCOS; hypothesis-generating and requires prospective validation before any clinical role.
No takes yet. Share an insight, caveat, or question.
Okşen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: